ArticleHealth science reports2025
Comparative Evaluation of Incidence of Cardiovascular Events Among Different Drug-Eluting Stent Features: A Retrospective Cohort Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative Evaluation of Incidence of Cardiovascular Events Among Different Drug-Eluting Stent Features: A Retrospective Cohort Study.Health science reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Coronary artery disease (CAD) is often treated with percutaneous coronary intervention (PCI). Various stent types are used during PCI, potentially resulting in different outcomes. Here, we compared major adverse cardiovascular events (MACE) across different stents over a 5-year follow-up post-PCI. Methods: This retrospective cohort study analyzed individuals receiving PCI from Iranian databases. Inclusion criteria encompassed drug-eluting stent recipients, excluding emergency surgical cases. Demographics, medical history, angiography, PCI details, and follow-up on MACE were collected and analyzed using Cox regression analyses. Results: Out of 4159 recruited patients, MACE were observed in 10.2% of individuals over 5 years. Factors significantly associated with MACE included a history of heart failure (HR: 2.58, 95% CI: 1.92-3.47), hypertension (HR: 1.87, 95% CI: 1.52-2.30), and lower baseline ejection fraction (HR: 0.975, 95% CI: 0.952-0.997). Procedural elements like the number of stents used (HR: 1.008, 95% CI: 1.005-1.012) and their total length (HR: 1.008, 95% CI: 1.005-1.012) were also significant predictors. No significant relationship was found between the types of drug-eluting stents and MACE. Conclusion: In a 5-year study of post-PCI patients, MACE rates were higher in those with lower ejection fractions and those with more stented vessels and longer stents but similar across different drug-eluting stents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.